Guided Therapeutics (GTHP) Work In Process (2014 - 2021)
Guided Therapeutics (GTHP) reported Work In Process of $80000.0 for Q1 2021, down 1.23% on a YoY basis from $81000.0 in Q1 2020, and little changed sequentially from $80000.0 in Q4 2020.
Guided Therapeutics (GTHP) Work In Process (2014 - 2021) Analysis & Trends
Guided Therapeutics (GTHP) has 8 years of Work In Process data on file, last reported at $80000.0 in Q1 2021.
- For the quarter ending Q1 2021, Work In Process fell 1.23% year-over-year to $80000.0; the trailing twelve-month figure through Mar 2021 stood at $80000.0 (down 1.23% YoY), and the FY2020 full-year result was $80000.0, down 1.23% from the prior year.
- Work In Process held at $80000.0 in Q1 2021, from $80000.0 in the prior quarter.
- In the past five years, Work In Process ranged from a high of $115000.0 in Q1 2017 to a low of $80000.0 in Q3 2020.
- A 5-year average of $85000.0 and a median of $81000.0 in 2018 frame the typical range for Work In Process.
- Across the five-year window, Work In Process slumped 69.37% in 2017 and changed 0.0% in 2019, its largest moves.
- Tracing GTHP's Work In Process over 5 years: stood at $82000.0 in 2017, then declined by 1.22% to $81000.0 in 2018, then changed by 0.0% to $81000.0 in 2019, then fell by 1.23% to $80000.0 in 2020, then changed by 0.0% to $80000.0 in 2021.
- Business Quant data shows GTHP's Work In Process at $80000.0 in Q1 2021, $80000.0 in Q4 2020, and $80000.0 in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Guided Therapeutics | 21.96 Mn | 21.89 Mn | 458,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 80,000.00 |
| Dec 31, 2020 | 80,000.00 |
| Sep 30, 2020 | 80,000.00 |
| Jun 30, 2020 | 81,000.00 |
| Mar 31, 2020 | 81,000.00 |
| Dec 31, 2019 | 81,000.00 |
| Sep 30, 2019 | 81,000.00 |
| Jun 30, 2019 | 81,000.00 |
| Mar 31, 2019 | 81,000.00 |
| Dec 31, 2018 | 81,000.00 |
| Sep 30, 2018 | 81,000.00 |
| Jun 30, 2018 | 81,000.00 |
| Mar 31, 2018 | 81,000.00 |
| Dec 31, 2017 | 82,000.00 |
| Sep 30, 2017 | 83,000.00 |
| Jun 30, 2017 | 115,000.00 |
| Mar 31, 2017 | 115,000.00 |
| Dec 31, 2016 | 115,000.00 |
| Sep 30, 2016 | 271,000.00 |
| Jun 30, 2016 | 285,000.00 |